Catherine Schulte
Stock Analyst at Baird
(1.66)
# 1401
Out of 5,344 analysts
139
Total ratings
50.00%
Success rate
5.91%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
A Agilent Technologies | Maintains: Outperform | 159 140 | 108.54 | 28.98% | 16 | May 22, 2025 | |
MRVI Maravai LifeSciences | Maintains: Neutral | 3 2 | 2.23 | -10.31% | 6 | May 13, 2025 | |
EXAS Exact Sciences | Maintains: Outperform | 69 72 | 56.76 | 26.85% | 14 | May 2, 2025 | |
AVTR Avantor | Maintains: Outperform | 21 17 | 12.66 | 34.28% | 11 | Apr 28, 2025 | |
TMO Thermo Fisher Scient... | Maintains: Outperform | 603 573 | 394.4 | 45.28% | 26 | Apr 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 231 225 | 185.23 | 21.47% | 8 | Apr 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1369 1034 | 1112.36 | -7.04% | 8 | Apr 22, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 42 43 | 42.01 | 2.36% | 4 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 88 68 | 46.75 | 45.45% | 9 | Feb 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 182 165 | n/a | n/a | 6 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 38 | 16.02 | 137.2% | 7 | Mar 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 56 33 | 28.36 | 16.36% | 3 | Nov 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | n/a | n/a | 1 | Jun 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 335 281 | 80 | 251.25% | 6 | Sep 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 21 | n/a | n/a | 1 | May 26, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 29 | n/a | n/a | 5 | Apr 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 208 217 | 344 | -36.92% | 7 | Oct 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 20 | 153.53 | -86.97% | 1 | Jun 28, 2018 |